| Market Cap | 718.49M | P/E | 250.75 | EPS this Y | -6.20% | Ern Qtrly Grth | - |
| Income | -77.44M | Forward P/E | -8.88 | EPS next Y | 5.50% | 50D Avg Chg | -20.00% |
| Sales | 426.1M | PEG | 0.01 | EPS past 5Y | - | 200D Avg Chg | -41.00% |
| Dividend | N/A | Price/Book | 2.46 | EPS next 5Y | -318.90% | 52W High Chg | -62.00% |
| Recommedations | 3.30 | Quick Ratio | 3.41 | Shares Outstanding | 37.28M | 52W Low Chg | 9.00% |
| Insider Own | 3.70% | ROA | -10.00% | Shares Float | 36.23M | Beta | 0.94 |
| Inst Own | 97.77% | ROE | -27.22% | Shares Shorted/Prior | 2.93M/3.04M | Price | 20.06 |
| Gross Margin | 68.06% | Profit Margin | -18.18% | Avg. Volume | 586,372 | Target Price | 10.13 |
| Oper. Margin | -23.20% | Earnings Date | Oct 30 | Volume | 2,296,174 | Change | -18.69% |
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.
| Citigroup | Neutral | Oct 1, 24 |
| Citigroup | Neutral | Aug 9, 24 |
| Wolfe Research | Peer Perform | Aug 8, 24 |
| Truist Securities | Hold | Aug 8, 24 |
| JMP Securities | Market Perform | Aug 7, 24 |
| RBC Capital | Sector Perform | Aug 7, 24 |
| Baird | Neutral | Aug 7, 24 |
| Wells Fargo | Underweight | Aug 7, 24 |
| JP Morgan | Underweight | Aug 7, 24 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Rashid Kashif | General Counsel General Counsel | May 09 | Buy | 44.5005 | 2,250 | 100,126 | 53,526 | 05/10/22 |
| Rashid Kashif | General Counsel General Counsel | Mar 11 | Buy | 64.0448 | 1,500 | 96,067 | 51,276 | 03/14/22 |
| GROSSMAN D KEITH | Chairman, President.. Chairman, President & CEO | Mar 08 | Buy | 63.59 | 3,200 | 203,488 | 169,290 | 03/08/22 |
| OBOYLE KEVIN C | Director Director | Dec 14 | Buy | 83.78 | 2,400 | 201,072 | 13,318 | 12/16/21 |
| WEATHERMAN ELIZABETH H | Director Director | Nov 22 | Buy | 85.3 | 20,000 | 1,706,000 | 38,328 | 11/22/21 |
| McCormick Shawn | Director Director | May 26 | Sell | 149.65 | 482 | 72,131 | 7,290 | 05/26/21 |
| Pellegrini Niamh Louise | Chief Commercial Off.. Chief Commercial Officer | Feb 12 | Option | 64.95 | 750 | 48,712 | 31,078 | 02/12/21 |
| Pellegrini Niamh Louise | Chief Commercial Off.. Chief Commercial Officer | Feb 12 | Sell | 182.55 | 750 | 136,912 | 30,328 | 02/12/21 |
| Pellegrini Niamh Louise | Chief Commercial Off.. Chief Commercial Officer | Jan 13 | Option | 64.95 | 750 | 48,712 | 31,078 | 01/13/21 |
| Pellegrini Niamh Louise | Chief Commercial Off.. Chief Commercial Officer | Jan 13 | Sell | 169.8 | 750 | 127,350 | 30,328 | 01/13/21 |
| Pellegrini Niamh Louise | Chief Commercial Off.. Chief Commercial Officer | Dec 14 | Option | 64.95 | 750 | 48,712 | 31,078 | 12/14/20 |
| Pellegrini Niamh Louise | Chief Commercial Off.. Chief Commercial Officer | Dec 14 | Sell | 161.34 | 750 | 121,005 | 30,328 | 12/14/20 |
| Pellegrini Niamh Louise | Chief Commercial Off.. Chief Commercial Officer | Oct 13 | Option | 64.95 | 750 | 48,712 | 33,895 | 10/13/20 |
| Pellegrini Niamh Louise | Chief Commercial Off.. Chief Commercial Officer | Oct 13 | Sell | 150.74 | 1,750 | 263,795 | 33,145 | 10/13/20 |
| Pellegrini Niamh Louise | Chief Commercial Off.. Chief Commercial Officer | Sep 14 | Option | 64.95 | 750 | 48,712 | 34,895 | 09/14/20 |
| Pellegrini Niamh Louise | Chief Commercial Off.. Chief Commercial Officer | Sep 14 | Sell | 139.14 | 750 | 104,355 | 34,145 | 09/14/20 |